CN109200207A - A kind of Chinese medicine composition for treating xerophthalmia - Google Patents

A kind of Chinese medicine composition for treating xerophthalmia Download PDF

Info

Publication number
CN109200207A
CN109200207A CN201710521451.3A CN201710521451A CN109200207A CN 109200207 A CN109200207 A CN 109200207A CN 201710521451 A CN201710521451 A CN 201710521451A CN 109200207 A CN109200207 A CN 109200207A
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine composition
xerophthalmia
taenian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710521451.3A
Other languages
Chinese (zh)
Inventor
陆文秀
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201710521451.3A priority Critical patent/CN109200207A/en
Publication of CN109200207A publication Critical patent/CN109200207A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287—Chrysanthemum, e.g. daisy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/41—Crassulaceae (Stonecrop family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482—Cassia, e.g. golden shower tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/535—Perilla (beefsteak plant)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A61K36/8988—Gastrodia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of Chinese medicine compositions for treating xerophthalmia, are mainly made of the raw material of following weight ratio: 10 parts of chrysanthemum, 5-25 parts of the bark of ash, 10-20 parts of Semen Cuscutae, 10-30 parts of Rhizoma Gastrodiae, 15-25 parts of caulis bambusae in taenian, 5-35 parts of Cassia occidentalis, 10-20 parts of scouring rush, 5-25 parts of root of kirilow rhodiola, 10-25 parts of glutinous rehmannia, 5-25 parts of purple perilla, 10-30 parts of Dicliptera chinensis, 10-20 parts of fuling peel, 5-35 parts of kaladana.Compared with prior art, Traditional Chinese medicine composition formula of the present invention is simple, and compatibility is rigorous, and dosage is accurate, can effectively treat xerophthalmia, effect is good and side effect is low, and patient adaptability is strong.

Description

A kind of Chinese medicine composition for treating xerophthalmia
Technical field
The present invention relates to a kind of Chinese medicine compositions for treating xerophthalmia, belong to technical field of traditional Chinese medicine preparation.
Background technique
Xerophthalmia refers to that tear matter caused by any reason or amount exception or dynamics are abnormal, causes under tear film stability Drop, and with ophthalmic uncomfortable and (or) the general name of a variety of diseases of ocular lesion tissue feature.Also known as angle xerosis of conjunctiva.It is common Symptom to include that eyes are dry and astringent, are easy tired, eye itch, has sticky foreign body sensation, pain burning heat sensation, secretion, fear of wind, photophobia, externally Boundary's stimulation is very sensitive；Sometimes eyes are too dry, basic oligodacrya, stimulate reflexive lacrimal secretion instead, and cause usually to shed tears； More severe case eyes can redness, hyperemia, keratinization, corneal epithelium broken skin and there is filiform to stick, with the passing of time this damage can then make Angulation conjunctive disorder, and will affect eyesight.The cause of disease can be divided into following four classes: 1. aqueous layer lachrymal gland lacrimal secretion are insufficient: being most often The dry eyes angle reason seen；Congenital alacrima gland, senile lacrimal gland function reduce or some autoimmune diseases cause tear Gland inflammation, wound, infection, vegetative dystonie, lacrimal secretion can all be caused by putting certain eyedrops for a long time or taking some drugs It is insufficient；The person that wears contact lenses for a long time.2. oil layer hyposecretion: since eyelid disease causes Meibomian gland dysfunction.3. viscous egg White hyposecretion: the A1 person that is deficient in vitamin, chronic conjunctivitis, chemical burn etc..4. tear excessive evaporation, tear film are distributed not Uniform: eyelid disease causes eyelid to be closed bad, number of winks to reduce, rest on cold air room for a long time or outdoor high wind is scorching In environment.
Although being all mostly chemical drug, it is big that there are side effects, and preventive effect is not currently, having the drug for the treatment of xerophthalmia Very ideal defect.
Summary of the invention
Goal of the invention: in view of the above technical problems, the present invention provides a kind of Chinese medicine compositions for treating xerophthalmia.
Technical solution: to achieve the above object of the invention, the present invention provides a kind of Chinese medicine composition for treating xerophthalmia, master It to be made of the raw material of following weight ratio:
10 parts of chrysanthemum, 5-25 parts of the bark of ash, 10-20 parts of Semen Cuscutae, 10-30 parts of Rhizoma Gastrodiae, 15-25 parts of caulis bambusae in taenian,
5-35 parts of Cassia occidentalis, 10-20 parts of scouring rush, 5-25 parts of root of kirilow rhodiola, 10-25 parts of glutinous rehmannia, 5-25 parts of purple perilla,
10-30 parts of Dicliptera chinensis, 10-20 parts of fuling peel, 5-35 parts of kaladana.
It is preferred that the Chinese medicine composition of the treatment xerophthalmia is mainly made of the raw material of following weight ratio:
10 parts of chrysanthemum, 10-20 parts of the bark of ash, 12-18 parts of Semen Cuscutae, 15-25 parts of Rhizoma Gastrodiae, 18-22 parts of caulis bambusae in taenian,
10-30 parts of Cassia occidentalis, 12-18 parts of scouring rush, 10-20 parts of root of kirilow rhodiola, 15-20 parts of glutinous rehmannia, 10-20 parts of purple perilla,
15-25 parts of Dicliptera chinensis, 12-18 parts of fuling peel, 10-30 parts of kaladana.
It is preferred that the Chinese medicine composition of the treatment xerophthalmia is mainly made of the raw material of following weight ratio:
10 parts of chrysanthemum, 10-20 parts of the bark of ash, 12-18 parts of Semen Cuscutae, 15-25 parts of Rhizoma Gastrodiae, 18-22 parts of caulis bambusae in taenian,
10-30 parts of Cassia occidentalis, 10-20 parts of scouring rush, 5-25 parts of root of kirilow rhodiola, 10-25 parts of glutinous rehmannia, 5-25 parts of purple perilla,
10-30 parts of Dicliptera chinensis, 10-20 parts of fuling peel, 5-35 parts of kaladana.
It is preferred that the Chinese medicine composition of the treatment xerophthalmia is mainly made of the raw material of following weight ratio:
10 parts of chrysanthemum, 5-25 parts of the bark of ash, 10-20 parts of Semen Cuscutae, 10-30 parts of Rhizoma Gastrodiae, 15-25 parts of caulis bambusae in taenian,
5-35 parts of Cassia occidentalis, 12-18 parts of scouring rush, 10-20 parts of root of kirilow rhodiola, 15-20 parts of glutinous rehmannia, 10-20 parts of purple perilla,
15-25 parts of Dicliptera chinensis, 12-18 parts of fuling peel, 10-30 parts of kaladana.
It is preferred that the Chinese medicine composition is liquid preparation or solid pharmaceutical preparation.
It is preferred that the liquid preparation is oral solution, injection, suspending agent, decoction or emulsion.
It is preferred that the solid pharmaceutical preparation is capsule, tablet, granule, pill or dripping pill.
The utility model has the advantages that compared with prior art, Traditional Chinese medicine composition formula of the present invention is simple, and compatibility is rigorous, dosage essence Really, xerophthalmia can be effectively treated, effect is good and side effect is low, and patient adaptability is strong.
Specific embodiment
According to following embodiments, the present invention may be better understood.However, as it will be easily appreciated by one skilled in the art that real It applies content described in example and is merely to illustrate the present invention, without sheet described in detail in claims should will not be limited Invention.
Embodiment 1
Prescription:
10 parts of chrysanthemum, 5 parts of the bark of ash, 10 parts of Semen Cuscutae, 10 parts of Rhizoma Gastrodiae, 15 parts of caulis bambusae in taenian,
5 parts of Cassia occidentalis, 10 parts of scouring rush, 5 parts of root of kirilow rhodiola, 10 parts of glutinous rehmannia, 5 parts of purple perilla,
10 parts of Dicliptera chinensis, 10 parts of fuling peel, 5 parts of kaladana.
Preparation method:
(1) chrysanthemum, the bark of ash, Semen Cuscutae, Rhizoma Gastrodiae, caulis bambusae in taenian, Cassia occidentalis and scouring rush are taken, 80% ethyl alcohol of 6 times of volumes is added, is returned Stream extracts 3 times, and 2 hours every time, combined extract was concentrated to give liquid extract A；
(2) root of kirilow rhodiola, glutinous rehmannia, purple perilla, Dicliptera chinensis, fuling peel and kaladana are taken, the pure water of 8 times of volumes is added, heating is boiled Boiling, refluxing extraction 3 times, 2 hours every time, combined extract was concentrated to give liquid extract B；
(3) above-mentioned liquid extract A and liquid extract B is merged and is mixed, room temperature is for 24 hours；
(4) it filters, customary adjuvant is added, liquid preparation or solid pharmaceutical preparation is made.
Embodiment 2
Prescription:
10 parts of chrysanthemum, 25 parts of the bark of ash, 20 parts of Semen Cuscutae, 30 parts of Rhizoma Gastrodiae, 25 parts of caulis bambusae in taenian,
35 parts of Cassia occidentalis, 20 parts of scouring rush, 25 parts of root of kirilow rhodiola, 25 parts of glutinous rehmannia, 25 parts of purple perilla,
30 parts of Dicliptera chinensis, 20 parts of fuling peel, 35 parts of kaladana.
Preparation method:
(1) chrysanthemum, the bark of ash, Semen Cuscutae, Rhizoma Gastrodiae, caulis bambusae in taenian, Cassia occidentalis and scouring rush are taken, 80% ethyl alcohol of 10 times of volumes is added, Refluxing extraction 3 times, 4 hours every time, combined extract was concentrated to give liquid extract A；
(2) root of kirilow rhodiola, glutinous rehmannia, purple perilla, Dicliptera chinensis, fuling peel and kaladana are taken, the pure water of 12 times of volumes is added, heating is boiled Boiling, refluxing extraction 3 times, 4 hours every time, combined extract was concentrated to give liquid extract B；
(3) above-mentioned liquid extract A and liquid extract B is merged and is mixed, room temperature 48h；
(4) it filters, customary adjuvant is added, liquid preparation or solid pharmaceutical preparation is made.
Embodiment 3
Prescription:
10 parts of chrysanthemum, 10 parts of the bark of ash, 12 parts of Semen Cuscutae, 15 parts of Rhizoma Gastrodiae, 18 parts of caulis bambusae in taenian,
10 parts of Cassia occidentalis, 12 parts of scouring rush, 10 parts of root of kirilow rhodiola, 15 parts of glutinous rehmannia, 10 parts of purple perilla,
15 parts of Dicliptera chinensis, 12 parts of fuling peel, 10 parts of kaladana.
Preparation method:
(1) chrysanthemum, the bark of ash, Semen Cuscutae, Rhizoma Gastrodiae, caulis bambusae in taenian, Cassia occidentalis and scouring rush are taken, 80% ethyl alcohol of 8 times of volumes is added, is returned Stream extracts 3 times, and 3 hours every time, combined extract was concentrated to give liquid extract A；
(2) root of kirilow rhodiola, glutinous rehmannia, purple perilla, Dicliptera chinensis, fuling peel and kaladana are taken, the pure water of 10 times of volumes is added, heating is boiled Boiling, refluxing extraction 3 times, 3 hours every time, combined extract was concentrated to give liquid extract B；
(3) above-mentioned liquid extract A and liquid extract B is merged and is mixed, room temperature 36h；
(4) it filters, customary adjuvant is added, liquid preparation or solid pharmaceutical preparation is made.
Embodiment 4
Prescription:
10 parts of chrysanthemum, 20 parts of the bark of ash, 18 parts of Semen Cuscutae, 25 parts of Rhizoma Gastrodiae, 22 parts of caulis bambusae in taenian,
30 parts of Cassia occidentalis, 18 parts of scouring rush, 20 parts of root of kirilow rhodiola, 20 parts of glutinous rehmannia, 20 parts of purple perilla,
25 parts of Dicliptera chinensis, 18 parts of fuling peel, 30 parts of kaladana.
Preparation method:
(1) chrysanthemum, the bark of ash, Semen Cuscutae, Rhizoma Gastrodiae, caulis bambusae in taenian, Cassia occidentalis and scouring rush are taken, 80% ethyl alcohol of 6 times of volumes is added, is returned Stream extracts 3 times, and 4 hours every time, combined extract was concentrated to give liquid extract A；
(2) root of kirilow rhodiola, glutinous rehmannia, purple perilla, Dicliptera chinensis, fuling peel and kaladana are taken, the pure water of 12 times of volumes is added, heating is boiled Boiling, refluxing extraction 3 times, 2 hours every time, combined extract was concentrated to give liquid extract B；
(3) above-mentioned liquid extract A and liquid extract B is merged and is mixed, room temperature 30h；
(4) it filters, customary adjuvant is added, liquid preparation or solid pharmaceutical preparation is made.
Experimental example:
The traditional chinese medicine composition of the invention is for treating xerophthalmia, effective percentage reachable 85.2%, and medication phase it has been confirmed by experiments that Between, no side reaction occurs.

Claims (7)

1. a kind of Chinese medicine composition for treating xerophthalmia, which is characterized in that it is mainly made of the raw material of following weight ratio:
10 parts of chrysanthemum, 5-25 parts of the bark of ash, 10-20 parts of Semen Cuscutae, 10-30 parts of Rhizoma Gastrodiae, 15-25 parts of caulis bambusae in taenian, 5-35 parts of Cassia occidentalis, wood 10-20 parts crafty, 5-25 parts of root of kirilow rhodiola, 5-25 parts of purple perilla, 10-30 parts of Dicliptera chinensis, 10-20 parts of fuling peel, is led 10-25 parts of glutinous rehmannia 5-35 parts of ox.
2. the Chinese medicine composition for the treatment of xerophthalmia according to claim 1, which is characterized in that it is mainly by following parts by weight The raw material of ratio is made:
10 parts of chrysanthemum, 10-20 parts of the bark of ash, 12-18 parts of Semen Cuscutae, 15-25 parts of Rhizoma Gastrodiae, 18-22 parts of caulis bambusae in taenian, 10-30 parts of Cassia occidentalis, 12-18 parts of scouring rush, 10-20 parts of root of kirilow rhodiola, 15-20 parts of glutinous rehmannia, 10-20 parts of purple perilla, 15-25 parts of Dicliptera chinensis, fuling peel 12-18 Part, 10-30 parts of kaladana.
3. the Chinese medicine composition for the treatment of xerophthalmia according to claim 1, which is characterized in that it is mainly by following parts by weight The raw material of ratio is made:
10 parts of chrysanthemum, 10-20 parts of the bark of ash, 12-18 parts of Semen Cuscutae, 15-25 parts of Rhizoma Gastrodiae, 18-22 parts of caulis bambusae in taenian, 10-30 parts of Cassia occidentalis, 10-20 parts of scouring rush, 5-25 parts of root of kirilow rhodiola, 10-25 parts of glutinous rehmannia, 5-25 parts of purple perilla, 10-30 parts of Dicliptera chinensis, 10-20 parts of fuling peel, 5-35 parts of kaladana.
4. the Chinese medicine composition for the treatment of xerophthalmia according to claim 1, which is characterized in that it is mainly by following parts by weight The raw material of ratio is made:
10 parts of chrysanthemum, 5-25 parts of the bark of ash, 10-20 parts of Semen Cuscutae, 10-30 parts of Rhizoma Gastrodiae, 15-25 parts of caulis bambusae in taenian, 5-35 parts of Cassia occidentalis, wood 12-18 parts crafty, 10-20 parts of root of kirilow rhodiola, 15-20 parts of glutinous rehmannia, 10-20 parts of purple perilla, 15-25 parts of Dicliptera chinensis, 12-18 parts of fuling peel, 10-30 parts of kaladana.
5. the Chinese medicine composition for the treatment of xerophthalmia according to claim 1, which is characterized in that the Chinese medicine composition is liquid Body preparation or solid pharmaceutical preparation.
6. the Chinese medicine composition for the treatment of xerophthalmia according to claim 5, which is characterized in that the liquid preparation is oral Liquid, injection, suspending agent, decoction or emulsion.
7. the Chinese medicine composition for the treatment of xerophthalmia according to claim 5, which is characterized in that the solid pharmaceutical preparation is capsule Agent, tablet, granule, pill or dripping pill.
CN201710521451.3A 2017-06-30 2017-06-30 A kind of Chinese medicine composition for treating xerophthalmia Pending CN109200207A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710521451.3A CN109200207A (en) 2017-06-30 2017-06-30 A kind of Chinese medicine composition for treating xerophthalmia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710521451.3A CN109200207A (en) 2017-06-30 2017-06-30 A kind of Chinese medicine composition for treating xerophthalmia

Publications (1)

Publication Number Publication Date
CN109200207A true CN109200207A (en) 2019-01-15

Family

ID=64960923

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710521451.3A Pending CN109200207A (en) 2017-06-30 2017-06-30 A kind of Chinese medicine composition for treating xerophthalmia

Country Status (1)

Country Link
CN (1) CN109200207A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111248349A (en) * 2020-04-08 2020-06-09 南京欣腾瑞生物科技有限公司 Formula of nutritional supplement for improving tear stains of pet dogs and preparation method of nutritional supplement

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111248349A (en) * 2020-04-08 2020-06-09 南京欣腾瑞生物科技有限公司 Formula of nutritional supplement for improving tear stains of pet dogs and preparation method of nutritional supplement

Similar Documents

Publication Publication Date Title
Pinheiro et al. Nature as a source of drugs for ophthalmology
CN103393969A (en) Eye drop used for releasing eye fatigue and preparation method thereof
CN103110810A (en) Traditional Chinese medicine preparation for treating dry eye diseases
CN106539083A (en) It is a kind of to be used to prevent and treat diabetic retinopathy, alleviate asthenopic compositionss
CN105106318B (en) A kind of Chinese medicine composition and preparation method thereof for treating xerophthalmia
CN103393915A (en) Chinese medicinal preparation for treating xerophthalmia
CN107753554A (en) A kind of prepared slices of Chinese crude drugs for eyeshield
CN109200207A (en) A kind of Chinese medicine composition for treating xerophthalmia
CN106963770A (en) It is a kind of to be used to prevent and treat eye drops of drying property angle/conjunctivitis and its production and use
CN110151827A (en) A kind of traditional Chinese medicine for outer use for treating xerophthalmia
CN106262850A (en) A kind of miscellaneous grain crops health instant powder and production technology
CN101181490B (en) Chinese medicine composition orally taken for curing glaucoma
CN104857287A (en) Traditional Chinese medicine eye-drop for treating xeroma and preparation method thereof
CN109200208A (en) A kind of preparation method for treating xerophthalmia Chinese medicine composition
CN104491506A (en) Traditional Chinese medicine for alleviating asthenopia
CN108210714A (en) It is a kind of for pharmaceutical composition of eye surface diseases and preparation method thereof and purposes
KR20190076732A (en) Composition for treatment and prevention of dry eye syndrome comprising mixed extract or fraction thereof
CN102940753B (en) Pills for treating glaucoma and preparation method
CN102920911B (en) Traditional Chinese medicine for treating keratoconjunctivitis sicca and preparation method thereof
CN107648397B (en) Traditional Chinese medicine composition for treating liver-kidney yin deficiency and preparation method and application thereof
CN103948633A (en) Eye drops for treating oculopathy and preparation method thereof
CN105983006A (en) Composition for relieving visual fatigue and preparation method of composition
CN107773660A (en) A kind of Chinese medicine composition for treating dry eyes
CN106309779A (en) Eyedrop for relieving eye fatigue and preparation method thereof
CN109248160A (en) A kind of Eexternal-use Chinese medicine plaster for alleviating eye disease

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190115